These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21404598)

  • 41. A mutation at codon 516 in the rpoB gene of Mycobacterium leprae confers resistance to rifampin.
    Zhang L; Namisato M; Matsuoka M
    Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):468-72. PubMed ID: 15755201
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is drug-resistant Mycobacterium leprae a real cause for concern?: First approach to molecular monitoring of multibacillary Colombian patients with and without previous leprosy treatment.
    Guerrero MI; Colorado CL; Torres JF; León CI
    Biomedica; 2014 Apr; 34 Suppl 1():137-47. PubMed ID: 24968045
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multidrug therapy--the pathway for global leprosy elimination.
    al-Qubati Y; al-Kubati AS
    Indian J Lepr; 2000; 72(4):477-90. PubMed ID: 11212482
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Viability and drug sensitivity of M. leprae isolated from long-term WHO/MDT treated multibacillary leprosy patients.
    Habtemariam H
    Lepr Rev; 1999 Mar; 70(1):43-6. PubMed ID: 10405543
    [No Abstract]   [Full Text] [Related]  

  • 45. Primary multidrug-resistant leprosy, United States.
    Williams DL; Hagino T; Sharma R; Scollard D
    Emerg Infect Dis; 2013 Jan; 19(1):179-81. PubMed ID: 23260417
    [No Abstract]   [Full Text] [Related]  

  • 46. Screening of drug resistant strains of Mycobacterium leprae in lepromatous leprosy patients under multidrug treatment.
    Sreevatsa ; Girdhar BK; Desikan KV
    Indian J Med Res; 1988 Feb; 87():139-43. PubMed ID: 3294170
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of mono treatment and combined treatment on the morphology of Myco. lepare in the skin.
    Leiker DL
    Lepr Rev; 1975 Jun; 46(2 Suppl):73-9. PubMed ID: 1100967
    [No Abstract]   [Full Text] [Related]  

  • 48. Diaminodiphenylsulfone resistance of Mycobacterium leprae due to mutations in the dihydropteroate synthase gene.
    Kai M; Matsuoka M; Nakata N; Maeda S; Gidoh M; Maeda Y; Hashimoto K; Kobayashi K; Kashiwabara Y
    FEMS Microbiol Lett; 1999 Aug; 177(2):231-5. PubMed ID: 10474189
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug resistance in leprosy: lessons from past and future perspective.
    Gupta UD; Katoch VM
    Indian J Lepr; 1999; 71(4):451-63. PubMed ID: 10804973
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dapsone Resistance in Leprosy Patients Originally from American Samoa, United States, 2010-2012.
    Williams DL; Araujo S; Stryjewska BM; Scollard D
    Emerg Infect Dis; 2018 Aug; 24(8):1584-1585. PubMed ID: 30016255
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Leprosy treatment: Can we replace opinions with research?
    Scollard DM
    PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008636. PubMed ID: 33031407
    [No Abstract]   [Full Text] [Related]  

  • 52. [Research in developing countries: will leprosy vaccine be produced in Nepal?].
    Kurlberg G
    Nord Med; 1990; 105(12):338-9. PubMed ID: 2270200
    [TBL] [Abstract][Full Text] [Related]  

  • 53. China. Leprosy's last stand--or early days of a war of attrition?
    Stone R
    Science; 2010 Feb; 327(5968):939. PubMed ID: 20167759
    [No Abstract]   [Full Text] [Related]  

  • 54. In vivo susceptibility of Mycobacterium leprae to sitafloxacin (DU-6859a), either singly or in combination with rifampicin analogues.
    Dhople AM; Namba K
    Int J Antimicrob Agents; 2003 Mar; 21(3):251-5. PubMed ID: 12636987
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dapsone drug resistance in the MDT era.
    Roche PW; Neupane KD; Failbus SS; Butlin CR
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
    [No Abstract]   [Full Text] [Related]  

  • 56. WHO Expert Committee on Leprosy.
    World Health Organ Tech Rep Ser; 1988; 768():1-51. PubMed ID: 3140498
    [No Abstract]   [Full Text] [Related]  

  • 57. Author's reply.
    Sengupta U
    Indian J Dermatol Venereol Leprol; 2018; 84(4):445. PubMed ID: 29893300
    [No Abstract]   [Full Text] [Related]  

  • 58. Increasing Virulence in Leprosy Indicated by Global Mycobacterium spp.
    Levis W; Rendini T; Martiniuk F
    Emerg Infect Dis; 2018 Jan; 24(1):183a-184. PubMed ID: 29260683
    [No Abstract]   [Full Text] [Related]  

  • 59. A second case of multidrug-resistant Mycobacterium leprae isolated from a Japanese patient with relapsed lepromatous leprosy.
    Matsuoka M; Kashiwabara Y; Liangfen Z; Goto M; Kitajima S
    Int J Lepr Other Mycobact Dis; 2003 Sep; 71(3):240-3. PubMed ID: 14608820
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular detection of drug resistance in Mycobacterium leprae.
    Williams DL; Gillis TP
    Lepr Rev; 2004 Jun; 75(2):118-30. PubMed ID: 15282962
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.